Prolonged grief disorder treatment: An approach to COVID-19 grief
Fuente:
Redalyc
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
2023
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1876466875084308480 |
|---|---|
| author | Consuelo Bernarda Martínez-Medina |
| author_facet | Consuelo Bernarda Martínez-Medina |
| contents | Prolonged grief disorder treatment: An approach to COVID-19 grief Consuelo Bernarda Martínez-Medina Alain R. Rodríguez-Orozco Medicina 19 COVID treatment psychotherapy prolonged grief Background. It has been estimated that COVID-19 grief will affect approximately sixteen million people worldwide, while the prevalence of prolonged grief disorder (PGD) could rise to 40%.Objective To review treatments that can be administered to patients with PGD due to COVID-19.Method PUBMED and Google Scholar were searched with the following keywords: prolonged grief disorder, complicated grief, grief and psychotherapy, and treatment of prolonged grief, complicated grief or persistent complex grief.Results Fifty articles were reviewed on the efficacy of interpersonal therapy, rational emotional-behavioral therapy, supportive therapy, humanistic therapy, systemic family therapy, group therapy, writing therapy, Internet-based intervention, and a modality of cognitive behavioral therapy used with prolonged grief, metacognitive therapy, and acceptance and commitment therapy.Discussion and conclusion There is no consensus on the psychotherapeutic treatment of choice for people with PGD due to the loss of a family member to COVID-19. Group therapy is effective in reducing the intensity of uncomplicated grief, cognitive-behavioral therapy is highly efficacious in reducing the severity of grief, metacognitive therapy specifically designed for PGD has a positive impact on depression, anxiety, stress, rumination, and quality of life while Acceptance and Commitment Therapy is helpful for restoring spirituality. Psychotherapy is most effective when combined with drug therapy. It is suggested that comparative studies be undertaken of psychotherapeutic techniques for managing patients with PGD associated with COVID-19 and the adaptation of these techniques to virtual settings. 2023 reseña 0185-3325 https://www.redalyc.org/articulo.oa?id=58275589006 https://www.redalyc.org/journal/582/58275589006/ https://www.redalyc.org/journal/582/58275589006/html/ https://www.redalyc.org/journal/582/58275589006/58275589006.epub https://www.redalyc.org/journal/582/58275589006/movil https://doi.org/10.17711/SM.0185-3325.2023.021 en http://www.redalyc.org/revista.oa?id=582 Salud Mental application/pdf Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz Salud Mental (México) Num.3 Vol.46 |
| format | Artículo científico |
| id | redalyc_58275589006 |
| institution | Redalyc |
| language | en |
| publishDate | 2023 |
| publisher | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz |
| spellingShingle | Prolonged grief disorder treatment: An approach to COVID-19 grief Consuelo Bernarda Martínez-Medina Medicina 19 COVID treatment psychotherapy prolonged grief Prolonged grief disorder treatment: An approach to COVID-19 grief Consuelo Bernarda Martínez-Medina Alain R. Rodríguez-Orozco Medicina 19 COVID treatment psychotherapy prolonged grief Background. It has been estimated that COVID-19 grief will affect approximately sixteen million people worldwide, while the prevalence of prolonged grief disorder (PGD) could rise to 40%.Objective To review treatments that can be administered to patients with PGD due to COVID-19.Method PUBMED and Google Scholar were searched with the following keywords: prolonged grief disorder, complicated grief, grief and psychotherapy, and treatment of prolonged grief, complicated grief or persistent complex grief.Results Fifty articles were reviewed on the efficacy of interpersonal therapy, rational emotional-behavioral therapy, supportive therapy, humanistic therapy, systemic family therapy, group therapy, writing therapy, Internet-based intervention, and a modality of cognitive behavioral therapy used with prolonged grief, metacognitive therapy, and acceptance and commitment therapy.Discussion and conclusion There is no consensus on the psychotherapeutic treatment of choice for people with PGD due to the loss of a family member to COVID-19. Group therapy is effective in reducing the intensity of uncomplicated grief, cognitive-behavioral therapy is highly efficacious in reducing the severity of grief, metacognitive therapy specifically designed for PGD has a positive impact on depression, anxiety, stress, rumination, and quality of life while Acceptance and Commitment Therapy is helpful for restoring spirituality. Psychotherapy is most effective when combined with drug therapy. It is suggested that comparative studies be undertaken of psychotherapeutic techniques for managing patients with PGD associated with COVID-19 and the adaptation of these techniques to virtual settings. 2023 reseña 0185-3325 https://www.redalyc.org/articulo.oa?id=58275589006 https://www.redalyc.org/journal/582/58275589006/ https://www.redalyc.org/journal/582/58275589006/html/ https://www.redalyc.org/journal/582/58275589006/58275589006.epub https://www.redalyc.org/journal/582/58275589006/movil https://doi.org/10.17711/SM.0185-3325.2023.021 en http://www.redalyc.org/revista.oa?id=582 Salud Mental application/pdf Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz Salud Mental (México) Num.3 Vol.46 |
| title | Prolonged grief disorder treatment: An approach to COVID-19 grief |
| topic | Medicina 19 COVID treatment psychotherapy prolonged grief |
| url | https://www.redalyc.org/articulo.oa?id=58275589006 https://www.redalyc.org/journal/582/58275589006/ https://www.redalyc.org/journal/582/58275589006/html/ https://www.redalyc.org/journal/582/58275589006/58275589006.epub https://www.redalyc.org/journal/582/58275589006/movil https://doi.org/10.17711/SM.0185-3325.2023.021 |